RayzeBio, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q3 2023.

Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
13 Nov 2023

Quick Takeaways

  • RayzeBio, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q3 2023.
  • Headline metric: Return On Equity -7.6%.

What Changed

  • Return On Equity YoY change: <span class="text-red-600">-137%</span>.
  • Most recent SEC facts end date: 07 Nov 2023.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2023-11-07) highlights Return On Equity -7.6%, Return On Assets -3.0%, and Current Ratio 31.85x.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

16.5/100

Weak Confidence low

Return On Equity

-7.6%

Metric score 0.0/100

Return On Assets

-3%

Metric score 0.0/100

Financial Health

Current Ratio
31.85x

Strengths

NetIncomeLoss YoY

Watchpoints

Return On Equity, Return On Assets, and Current Ratio

Key metrics snapshot

Return On Equity

-7.6%

YoY: -137%

Industry median: -43% (n=675)

View history

Return On Assets

-3%

YoY:

Industry median: -47% (n=673)

View history

Current Ratio

31.85x

YoY:

Industry median: 3.39x (n=667)

View history

NetIncomeLoss YoY

11%

YoY:

Industry median: -0.93% (n=641)

View history

Profitability

Metric Latest value YoY change
Return On Equity -7.6% -137%
Return On Assets -3%

Financial Health

Metric Latest value YoY change
Current Ratio 31.85x

Growth

Metric Latest value YoY change
NetIncomeLoss YoY 11%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 59,919,502
Common Stock, Shares, Outstanding 59,826,184
Common Stock, Value, Issued $6,000
Weighted Average Number of Shares Outstanding, Basic 15,399,901 +303%
Weighted Average Number of Shares Outstanding, Diluted 15,399,901 +303%

Additional Metrics

Metric Latest value YoY change
Research and Development Expense $18,170,000 -3.5%
General and Administrative Expense $3,481,000 +64%
Operating Income (Loss) $21,651,000 -3.3%
Earnings Per Share, Basic -1.26 +81%
Earnings Per Share, Diluted -1.26 +81%
Cash and Cash Equivalents, at Carrying Value $251,964,000 +17%
Cash, Cash Equivalents, and Short-term Investments $540,200,000
Assets, Current $544,986,000
Property, Plant and Equipment, Net $49,696,000
Operating Lease, Right-of-Use Asset $8,484,000
Other Assets, Noncurrent $8,000
Assets $603,513,000
Accounts Payable, Current $2,237,000
Employee-related Liabilities, Current $3,076,000
Accrued Liabilities, Current $13,610,000
Liabilities, Current $17,113,000
Operating Lease, Liability, Noncurrent $8,458,000
Accumulated Other Comprehensive Income (Loss), Net of Tax $386,000
Retained Earnings (Accumulated Deficit) $180,127,000
Stockholders' Equity Attributable to Parent $575,322,000
Liabilities and Equity $603,513,000
Common Stock, Shares Authorized 700,000,000
Common Stock, Shares, Issued 61,047,189
Common Stock, Par or Stated Value Per Share 0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $252,303,000 +17%
Operating Lease, Liability $9,724,000
Depreciation $500,000 +25%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $19,220,000 +23%
Lessee, Operating Lease, Liability, to be Paid $12,579,000
Property, Plant and Equipment, Gross $52,990,000
Operating Lease, Liability, Current $1,266,000
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,132,000
Lessee, Operating Lease, Liability, to be Paid, Year One $2,070,000
Operating Lease, Weighted Average Discount Rate, Percent 0.09
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2,855,000
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,196,000
Preferred Stock, Shares Issued 0
Preferred Stock, Shares Authorized 10,000,000
Lessee, Operating Lease, Liability, to be Paid, Year Four $2,261,000
Operating Lease, Payments $501,000 +2.9%
Additional Paid in Capital $755,829,000
Preferred Stock, Shares Outstanding 0
Share-based Payment Arrangement, Expense $2,564,000 +77%
Preferred Stock, Par or Stated Value Per Share 0

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY